Question

I am a breastfeeding mother and i want to know if it is safe to use UNII-9266D9P3PQ? Is UNII-9266D9P3PQ safe for nursing mother and child? Does UNII-9266D9P3PQ extracts into breast milk? Does UNII-9266D9P3PQ has any long term or short term side effects on infants? Can UNII-9266D9P3PQ influence milk supply or can UNII-9266D9P3PQ decrease milk supply in lactating mothers?

Answer by DrLact: About UNII-9266D9P3PQ usage in lactation

No information is available on the use of UNII-9266D9P3PQ during breastfeeding. Most sources consider breastfeeding to be contraindicated during maternal antineoplastic drug therapy, especially alkylating agents such as UNII-9266D9P3PQ.[1] The manufacturer recommends that breastfeeding be discontinued during UNII-9266D9P3PQ therapy. Based on the half-life of the drug and its metabolites, the drug should be eliminated from the milk by 24-48 hours after the last dose.

UNII-9266D9P3PQ Possible Effects in Breastfeeding

Some evidence indicates that carmustine can increase serum prolactin.[2]

Alternate Drugs

Temozolamide
Dacarbazine(Dangerous)
Bendamustine
Carmustine(Dangerous)
Bendamustine
Carmustine(Dangerous)

Synonyms of UNII-9266D9P3PQ

Bendamustina [Spanish]
Bendamustinum [Latin]
SDX-105
SDX 105
Bendamustina
Bendamustinum
HSDB 7763
Bendeka
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.